An epidemiOlogy Study to deteRmine the Prevalence of EGFR (Epidermal Growth Factor Receptor) muTations in RUSsian Patients With Advanced NSCLC (Non-Small Cell Lung Cancer).
NCT02321046
·
clinicaltrials.gov ↗
COMPLETED
Status
26
Enrollment
INDUSTRY
Sponsor class
Conditions
Non-Small Cell Lung Cancer
Sponsor
AstraZeneca